Bicycle Therapeutics announces preliminary results from Ph1 oncology trials

Clinical Impact

Oct 7

Written By Frances Benson

https://investors.bicycletherapeutics.com/news-releases/news-release-details/bicycle-therapeutics-announces-interim-bt5528-phase-i-clinical

2021

Frances Benson

CRISPR Therapeutics reports positive results from its Ph1 CARBON Trial of CTX110™

Turning Point Therapeutics granted breakthrough therapy designation for Repotrectinib treatment